Innovation in Ireland →
Partner, Third Rock Ventures
Former CEO, Calistoga Pharmaceuticals
Managing director, the Foundry Group
Medical College of Wisconsin director of research commercialization
CEO and Fund Manager, Renaissance Venture Capital Fund
Founder and CEO, Acme Packet
May 6, 2015 ·
May 21, 2015 ·
June 1, 2015 ·
Matthew Scholz is the CEO of Immusoft, a (currently) Seattle based biotech startup that is commercializing technology to program the human immune system.
If Seattle is to occupy a future place of dominance in the biotech world, it must foster more of an “incubator” culture. There is a “valley of death” between the well-funded... Read more »
Xconomy offers a number of ways to subscribe for free!
Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York, Raleigh-Durham, Boulder/Denver, Texas, Wisconsin and beyond.
© 2007-2015, Xconomy, Inc.
Xconomy is a registered service mark of Xconomy, Inc.
All rights reserved.
Website development support from Andrew Koyfman with design support from Rob Hunter.